You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Genetics
Genetics
Currently selected
Sickle Cell Disease
What is Sickle Cell Disease?
What is Sickle Cell Trait?
How can SCT impact a person’s health?
What do I need to know about SCT and sports?
How is Sickle Cell Trait (SCT) Inherited?
What does the Maryland Department of Health’s Sickle Cell Disease Follow-Up Program do?
Section Menu
Office for Genetics and People with Special Health Care Needs
Currently selected
A-Z Index
Birth Defects Reporting Information System
Children's Medical Services
Critical Congenital Heart Disease
Early Hearing Detection and Intervention Program
Family Professional Partnership
Health Care Transition Program
Maternal and Child Health
Medical Home Program
Newborn Metabolic Screening
Sickle Cell Disease Follow-up Program
Special Needs Resource Locator
Recent
Left_Content
Main_Content
Provider’s Guide to Newborn Metabolic Screening Disorders
The state of Maryland screens for over 50 disorders including endocrine, hematologic, and metabolic disorders. Maryland recommends two newborn screens; the first should be collected after 24 hours of feeding and the second after 7 days of life. About 10% of congenital hypothyroidism is missed on the initial screen but is picked up by the subsequent screen. The second screen picks up several children each year with conditions that are not detectable on the initial screen and, therefore, is vital to our newborn screening program.
In order to maximize optimal outcomes for infants identified on the second screen, the recommended timeframe for collection of the second screen has been changed from 1-4 weeks to 10-14 days of age, but specimens can be collected as early as 7 days of age.
The timing for collection of the Newborn Screen differs for babies in the NICU. All babies admitted to the NICU should have a Newborn Screen collected as soon as possible after admission so the baby is screened prior to transfusion and initiation of antibiotics. Additional screens should be collected between 2-3 days of age, at the 10 day interval, and then again at 1 month or discharge (whichever comes first).
If your patient has an abnormal result that requires follow-up, the newborn screening follow-up team will call you and will work with you to create an appropriate follow-up plan for each baby.
Remember that every baby is different, so recommendations for follow-up of a particular abnormality may vary depending on circumstances; however, the links below can serve as a guideline for general disorder information.
Acylcarnitine Abnormalities
- (Organic Acidemias and Fatty Acid Oxidation Disorders)
Amino Acid Abnormalities
Biotinidase Deficiency
Congenital Adrenal Hyperplasia (CAH)
Congenital Hypothyroidism
Cystic Fibrosis
Fabry Disease
Galactosemia
Mucopolysaccharidoses Type I
- (MPS-I)
Pompe Disease
- (Glycogen Storage Disease Type II)
Severe Combined Immunodeficiency Disorder
Spinal Muscular Atrophy
updated 07/2019
Center_Content